On Apr. 15, 2026, Foundation Medicine, an independent affiliate of the Roche group, announced it is set to…
On Apr. 14, 2026, Amazon announces launching AI BioDiscovery Contract Research Orgainzation. Lab-in-the-loop drug discovery has transformed research…
On Apr. 14, 2026, a landmark study from researchers at the Texas A&M University Naresh K. Vashisht College…
On Apr. 14, 2026, Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI…
On Apr. 14, 2026, researchers from the Wellcome Sanger Institute, Cambridge University Hospitals NHS Foundation Trust (CUH), the…
On Apr. 11, 2026, in Science Advances, a team of U.S. researchers present a new approach to genetically…
On Apr. 9, 2026, scientists from the Wellcome Sanger Institute and the Universities of Oxford, Cambridge and Melbourne,…
On Apr. 8, 2026, the Trump administration will not be asking the Supreme Court to take up its…
On Apr. 7, 2026, Gilead Sciences announced it has entered into a definitive agreement to acquire Tubulis, a…
On Apr. 7, 2026, Cornell scientists announce they have taken a major step toward developing a safe, reversible,…
On Apr. 7, 2026, LifeScienceHistory.com, formerly WashingtonLifeScience.com, announces release of a report highlighting the challenges of Washington State’s…
On Apr. 6, 2026, scientists from the University of California, Los Angeles (UCLA) announce they have developed a…
On Apr. 6, 2026, a research team at the University of Tokyo announced they have developed a new…
On Apr. 2, 2026, Zhang Kai, a rising cryo-electron microscopy researcher, has resigned from his tenure-track position at…
On Apr. 1, 2026, a research team at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of…
On Apr. 1, 2026, Eli Lilly announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for…
On Mar. 31, 2026, the Organisation for Economic Co-operation and Development (OECD), reports that China has officially crept…
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
On Mar. 31, 2026, Eli Lilly and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines…
On Mar. 30, 2026, Biogen announced that the High Dose Regimen of SPINRAZA® (nusinersen), which is comprised of…
On Mar. 29, 2026, The South China Morning Post reported the cross-border outlicensing activities of Chinese biotech firms…
On Mar. 29, 2026, generative-AI drug developer Insilico Medicine announced that it has agreed to a global licensing…
On Mar. 27, 2026, a STAT survey conducted of nearly 1,000 National Institutes of Health (NIH) -supported scientists,…
On Mar. 27, 2026, Novartis announced an agreement to acquire Excellergy, a private biotech company developing next-generation anti-IgE…
On Mar. 27, 2026, A multi-institutional team of scientists, co-led by Northwestern University, has taken a crucial step…
On Mar. 27, 2026, measles cases in the United States have climbed to 1,575, with 88 new infections,…
On Mar. 27, 2026, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has granted accelerated approval…
On Mar. 26, 2026, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (USPTO and PTAB,…
On Mar. 26, 2026, Indiana’s poultry industry continues to face significant challenges as outbreaks of highly pathogenic avian…
On Mar. 25, 2026, Merck, and Terns Pharmaceuticals, a clinical-stage oncology company, announced that the companies have entered…